Suppr超能文献

表观遗传学作为癌症可塑性的介体。

Epigenetics as a mediator of plasticity in cancer.

机构信息

Center for Epigenetics, Johns Hopkins University Schools of Medicine, Biomedical Engineering, and Public Health, Baltimore, MD 21205, USA.

Yale Systems Biology Institute and Department of Biomedical Engineering, Yale University, West Haven, CT 06516, USA.

出版信息

Science. 2023 Feb 10;379(6632):eaaw3835. doi: 10.1126/science.aaw3835.

Abstract

The concept of an epigenetic landscape describing potential cellular fates arising from pluripotent cells, first advanced by Conrad Waddington, has evolved in light of experiments showing nondeterministic outcomes of regulatory processes and mathematical methods for quantifying stochasticity. In this Review, we discuss modern approaches to epigenetic and gene regulation landscapes and the associated ideas of entropy and attractor states, illustrating how their definitions are both more precise and relevant to understanding cancer etiology and the plasticity of cancerous states. We address the interplay between different types of regulatory landscapes and how their changes underlie cancer progression. We also consider the roles of cellular aging and intrinsic and extrinsic stimuli in modulating cellular states and how landscape alterations can be quantitatively mapped onto phenotypic outcomes and thereby used in therapy development.

摘要

描述多能细胞潜在细胞命运的表观遗传景观的概念,最初由 Conrad Waddington 提出,随着表明调控过程的非确定性结果和用于量化随机性的数学方法的实验而发展。在这篇综述中,我们讨论了表观遗传和基因调控景观的现代方法以及与之相关的熵和吸引子状态的概念,说明它们的定义如何更加精确和有助于理解癌症病因和癌变状态的可塑性。我们探讨了不同类型的调控景观之间的相互作用以及它们的变化如何构成癌症进展的基础。我们还考虑了细胞衰老以及内在和外在刺激在调节细胞状态中的作用,以及如何将景观改变定量映射到表型结果上,并将其用于治疗方法的开发。

相似文献

1
Epigenetics as a mediator of plasticity in cancer.
Science. 2023 Feb 10;379(6632):eaaw3835. doi: 10.1126/science.aaw3835.
2
Epigenetics and Cancer Stem Cells: Unleashing, Hijacking, and Restricting Cellular Plasticity.
Trends Cancer. 2017 May;3(5):372-386. doi: 10.1016/j.trecan.2017.04.004. Epub 2017 May 5.
3
Interplay between epigenetics, senescence and cellular redox metabolism in cancer and its therapeutic implications.
Redox Biol. 2024 Dec;78:103441. doi: 10.1016/j.redox.2024.103441. Epub 2024 Nov 23.
4
Perturbation-Driven Entropy as a Source of Cancer Cell Heterogeneity.
Trends Cancer. 2020 Jun;6(6):454-461. doi: 10.1016/j.trecan.2020.02.016. Epub 2020 Mar 13.
5
Cancer epigenetics: tumor heterogeneity, plasticity of stem-like states, and drug resistance.
Mol Cell. 2014 Jun 5;54(5):716-27. doi: 10.1016/j.molcel.2014.05.015.
6
Association of epigenetic landscapes with heterogeneity and plasticity in pancreatic cancer.
Crit Rev Oncol Hematol. 2025 Feb;206:104573. doi: 10.1016/j.critrevonc.2024.104573. Epub 2024 Nov 22.
7
The epigenetic basis of cellular plasticity.
Curr Opin Cell Biol. 2017 Dec;49:116-122. doi: 10.1016/j.ceb.2018.01.003. Epub 2018 Feb 4.
8
Dynamical analysis of cellular ageing by modeling of gene regulatory network based attractor landscape.
PLoS One. 2018 Jun 1;13(6):e0197838. doi: 10.1371/journal.pone.0197838. eCollection 2018.
9
Cellular Origins and Lineage Plasticity in Cancer.
Cold Spring Harb Perspect Med. 2024 Jun 3;14(6):a041389. doi: 10.1101/cshperspect.a041389.
10
Interplay between epigenetics and metabolism in oncogenesis: mechanisms and therapeutic approaches.
Oncogene. 2017 Jun 15;36(24):3359-3374. doi: 10.1038/onc.2016.485. Epub 2017 Jan 16.

引用本文的文献

1
The intrinsic dimension of gene expression during cell differentiation.
Nucleic Acids Res. 2025 Aug 27;53(16). doi: 10.1093/nar/gkaf805.
4
Colorectal cancer heterogeneity co-evolves with tumor architecture to determine disease outcome.
bioRxiv. 2025 Aug 13:2025.08.11.669722. doi: 10.1101/2025.08.11.669722.
6
Cancer progression through the lens of age-induced metabolic reprogramming.
Nat Rev Cancer. 2025 Jul 11. doi: 10.1038/s41568-025-00845-4.
7
Methylation aberrations and genomic instability synergistically drive the evolution of intrahepatic cholangiocarcinoma.
Epigenomics. 2025 Jul;17(10):661-674. doi: 10.1080/17501911.2025.2518919. Epub 2025 Jun 17.
8
Mutant EZH2 alters the epigenetic network and increases epigenetic heterogeneity in B cell lymphoma.
PLoS Biol. 2025 Jun 12;23(6):e3003191. doi: 10.1371/journal.pbio.3003191. eCollection 2025 Jun.
9
Mechanism and role of ferroptosis in the development of gastric cancer.
Clin Exp Med. 2025 May 29;25(1):182. doi: 10.1007/s10238-025-01722-y.
10
Harnessing technologies to unravel gastric cancer heterogeneity.
Trends Cancer. 2025 Aug;11(8):753-769. doi: 10.1016/j.trecan.2025.04.011. Epub 2025 May 27.

本文引用的文献

1
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast Cancer.
Cancer Discov. 2022 Apr 1;12(4):1022-1045. doi: 10.1158/2159-8290.CD-20-1265.
2
Epigenetic encoding, heritability and plasticity of glioma transcriptional cell states.
Nat Genet. 2021 Oct;53(10):1469-1479. doi: 10.1038/s41588-021-00927-7. Epub 2021 Sep 30.
4
A single-cell survey of cellular hierarchy in acute myeloid leukemia.
J Hematol Oncol. 2020 Sep 25;13(1):128. doi: 10.1186/s13045-020-00941-y.
5
Somatic Mutations Drive Specific, but Reversible, Epigenetic Heterogeneity States in AML.
Cancer Discov. 2020 Dec;10(12):1934-1949. doi: 10.1158/2159-8290.CD-19-0897. Epub 2020 Sep 16.
7
Large-Scale Topological Changes Restrain Malignant Progression in Colorectal Cancer.
Cell. 2020 Sep 17;182(6):1474-1489.e23. doi: 10.1016/j.cell.2020.07.030. Epub 2020 Aug 24.
8
Single-cell analysis of clonal maintenance of transcriptional and epigenetic states in cancer cells.
Nat Genet. 2020 Jul;52(7):709-718. doi: 10.1038/s41588-020-0645-y. Epub 2020 Jun 29.
9
Epigenetic silencing of AATK in acinar to ductal metaplasia in murine model of pancreatic cancer.
Clin Epigenetics. 2020 Jun 17;12(1):87. doi: 10.1186/s13148-020-00878-6.
10
State-Transition Analysis of Time-Sequential Gene Expression Identifies Critical Points That Predict Development of Acute Myeloid Leukemia.
Cancer Res. 2020 Aug 1;80(15):3157-3169. doi: 10.1158/0008-5472.CAN-20-0354. Epub 2020 May 15.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验